{
    "code": "02012701",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02012701",
    "time": "2016-11-18 18:28:09",
    "許可證字號": "衛署藥輸字第012701號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/11\/25",
    "註銷理由": "自請註銷",
    "有效日期": "88\/09\/11",
    "發證日期": "83\/08\/10",
    "許可證種類": "製　劑",
    "舊證字號": "02003692",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201270100",
    "中文品名": "使得安靜持續性藥效膠囊２公絲",
    "英文品名": "STELAZINE SPANSULE CAPSULES",
    "適應症": "精神病狀態、噁心、嘔吐、攻擊性與破壞性之行為障礙",
    "劑型": "133持續性藥效膠囊劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "TRIFLUOPERAZINE(2HCL)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1115901100  荷商史克美占遠東股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F130104000  SMITH KLINE &amp; FRENCH LAB. LTD.",
        "製造廠廠址": "WELWYN GARDEN CITY, HERTFORD SHIRE AL7 1EY",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816991310",
            "成分名稱": "TRIFLUOPERAZINE (2HCL)",
            "含量描述": "(2.360MG) 2.0",
            "含量": "",
            "單位": "MG"
        }
    ]
}